Alfonso fasano

Alfonso Fasano graduated from the Catholic University of Rome, Italy, in and became a neurologist in In he joined the Movement Alfonso fasano Centre at Toronto Western Hospital, where he is the co-director of the surgical program for movement disorders, alfonso fasano.

The system can't perform the operation now. Try again later. Citations per year. Duplicate citations. The following articles are merged in Scholar. Their combined citations are counted only for the first article.

Alfonso fasano

JavaScript is currently disabled. Please enable JavaScript for an optimal experience. Alfonso Fasano, MD, PhD, is author of more than papers in international journals with peer-review. He graduated from the Catholic University of Rome, Italy, in and became a neurologist in In he joined the Movement Disorder Centre at Toronto Western Hospital, where he is the co-director of the surgical program for movement disorders. He is also an associate professor of medicine in the Division of Neurology at the University of Toronto and clinician investigator at the Krembil Research Institute. The pathophysiological mechanisms behind clinical phenomena represent his principal field of interest. Indeed, unmet clinical needs drive his research as a profound understanding of such mechanisms is the first step in the formulation of the right answers. Presently, he is principal investigator of several clinical trials. Home Page. Search for topics, articles, videos, research, etc Hit enter to search or ESC to close. Are you looking for:. Donate Now. Location: Toronto ON Canada.

He graduated from the Catholic University of Rome, Italy, in and became a neurologist in He is also staff neurologist at the Hospital for the Sick Children of Toronto, alfonso fasano.

.

The professor of neurology at the University of Toronto provided insight on several prominent targets in the brain for deep brain stimulation, including emerging ones that may not gain as much attention. Introduced in the late s, the use of deep brain stimulation DBS has evolved significantly over time and is now considered an effective alternative treatment for patients with Parkinson disease PD. Originally, stimulation was predominantly being used to localize areas for selective brain ablation and as a method to avoid adverse events. Over time, research on patients with tremor led to the observation that lower frequency stimulation exacerbated motor symptoms, whereas high-frequency stimulation led to a reduction in symptoms. In , DBS for the treatment of neurologic symptoms, including dystonia, tremor, and speech impairment was first reported. Years later, research by A. Benabid et al showed the first successful chronic electrode implantation in the ventral intermediate VIM nucleus of the thalamus for treating tremor with DBS, in both essential tremor ET and PD.

Alfonso fasano

Scroll down to listen or click here to subscribe on your favorite streaming service. The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more. Episode , "Ways to Enhance Neuromodulation in Parkinsonism" features an interview with Alfonso Fasano, MD, PhD, professor of neurology at the University of Toronto and staff neurologist at Toronto Western Hospital, who spoke on the topic of neuromodulation in Parkinson disease and the potential targets clinicians should be learning about. He discussed the specific patient profiles who fit for neuromodulation, ways to improve this type of personalized medicine, and the needed research in this patient population going forward. Check out new content and shows every day, only at medicalworldnews. The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:.

Minecraft resource packs for pvp

Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? Neurology 92 7 , , Associated Grants. BAck to the Team. He graduated from the Catholic University of Rome, Italy, in and became a neurologist in Enable or Disable Cookies. Privacy Overview This website uses cookies so that we can provide you with the best user experience possible. He is principal investigator of several clinical trials. Location: Toronto ON Canada. This "Cited by" count includes citations to the following articles in Scholar. The pathophysiological mechanisms behind clinical phenomena represent his principal field of interest. He is also staff neurologist at the Hospital for the Sick Children of Toronto. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. First Name. Nature communications 12 1 , ,

JavaScript is currently disabled. Please enable JavaScript for an optimal experience.

Email address for updates. Annals of Neurology 84 6 , , New articles by this author. View all. Add co-authors Co-authors. Presently, he is principal investigator of several clinical trials. Nature communications 12 1 , , In he joined the Movement Disorder Centre at Toronto Western Hospital, where he is the co-director of the surgical program for movement disorders. Get my own profile Cited by View all All Since Citations h-index 68 56 iindex This means that every time you visit this website you will need to enable or disable cookies again. Enable or Disable Cookies. He is principal investigator of several clinical trials.